Functional Molecular Imaging In Hepatology

Indexed in: EBSCO.

The eBook discusses how the special physiology of the liver must be considered when applying functional molecular imaging in hepatology. The main topics of the eBook include the clinical and ...
[view complete introduction]


Hepatocellular Carcinoma

Pp. 87-94 (8)

DOI: 10.2174/978160805290511201010087

Author(s): Michael Sørensen


Hepatocellular carcinoma (HCC) is the most common primary liver cancer. HCC typically develops in a cirrhotic liver and the overall survival is poor, primarily because the disease is often diagnosed at an advanced stage, when curable treatment is no longer an option. Ideally, HCC lesions should be detected when they are ≤ 2-3 cm in diameter. The diagnosis of HCC has improved with the introduction of 4-phase contrast enhanced CT and dynamic, contrast enhanced MRI. However, for small lesions, which are potentially curable, the detection rate remains poor. Molecular imaging of specific metabolic pathways may provide new opportunities for early diagnosis of HCC.


Liver cancer; Cirrhosis; Contrast-enhanced CT; Dynamic MRI; PET.